Overall, the revelation that small molecule compounds can inhibit the catalytic function of dyskerin and the availability of a new fast assay to detect the dyskerin pseudouridylation activity invitro herein described, will pave the way to a pharmacological targeting of ribosome biogenesis in cancer cells. The gene discussed is DKC1; the disease is cancer.